4.5 Article

Synaptic vesicle glycoprotein 2A (SV2A) levels in the cerebral cortex in patients with Alzheimer's disease: a radioligand binding study in postmortem brains

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [11C]UCB-J

Adam P. Mecca et al.

Summary: This study examined the relationship between synaptic density and cognitive performance in early Alzheimer's disease patients using a new PET imaging technique. The results showed a significant positive correlation between synaptic density and cognitive performance, with synaptic density being a stronger predictor of cognitive ability.

ALZHEIMERS & DEMENTIA (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Imaging of Synaptic Density in Neurodegenerative Disorders

Richard E. Carson et al.

Summary: PET technology has developed radiopharmaceuticals targeting specific brain proteins. A new approach of imaging synaptic density by targeting SV2A protein has emerged. SV2A PET imaging shows potential clinical value and has been applied in various neurodegenerative diseases.

JOURNAL OF NUCLEAR MEDICINE (2022)

Article Geriatrics & Gerontology

Association of entorhinal cortical tau deposition and hippocampal synaptic density in older individuals with normal cognition and early Alzheimer's disease

Adam P. Mecca et al.

Summary: This study used PET imaging to measure the binding of SV2A and tau in the brains of AD patients and cognitively normal individuals. The results showed an inverse association between ERC tau and hippocampal synaptic density, suggesting that synaptic failure due to tau pathology in ERC neurons may play a role in AD.

NEUROBIOLOGY OF AGING (2022)

Article Neurosciences

Expression profile of synaptic vesicle glycoprotein 2A, B, and C paralogues in temporal neocortex tissue from patients with temporal lobe epilepsy (TLE)

Burcu A. Pazarlar et al.

Summary: This study analyzed the expression of SV2 genes in neuronal subtypes in the temporal neocortex and found that SV2A transcript is expressed in all glutamatergic and GABAergic cortical subtypes, SV2B expression is restricted to only the glutamatergic neurons, and SV2C has very limited expression in a small subgroup of GABAergic interneurons.

MOLECULAR BRAIN (2022)

Review Neurosciences

Synaptic Vesicle Glycoprotein 2A: Features and Functions

Rachele Rossi et al.

Summary: SV2A, a transmembrane protein of synaptic vesicles, serves as a potential marker of synaptic density with stronger associations to GABAergic synapses. Despite being ubiquitously expressed, the biological function and interaction between SV2A and its tracers remain unclear. Further research is required for a better understanding of the protein's involvement in neurotransmission and its implications in neuroimaging studies.

FRONTIERS IN NEUROSCIENCE (2022)

Review Neurosciences

Imaging Synaptic Density: The Next Holy Grail of Neuroscience?

Maria Elisa Serrano et al.

Summary: The brain is a complex organ composed of billions of neurons and trillions of synapses. Proper regulation of synaptic density is crucial for normal brain development, and abnormalities in synapses have been associated with various neurological and psychiatric disorders. Several methods, including PET and MRI, are being developed to measure synaptic density, but further research is needed to address their limitations before they can be used clinically.

FRONTIERS IN NEUROSCIENCE (2022)

Article Neurosciences

Spatio-Temporal Alterations in Synaptic Density During Epileptogenesis in the Rat Brain

Jens D. Mikkelsen et al.

Summary: The study reveals that the binding capacity of vesicle glycoprotein 2A (SV2A) is significantly reduced in the cerebral cortex and hippocampus after epilepsy occurs, while no significant changes are observed in the thalamus and hypothalamus. The regions with larger and earlier reductions include the hippocampus and piriform cortex. Interestingly, the binding capacity returns to control levels 12 weeks after the status epilepticus, similar to the chronic epileptic phase.

NEUROSCIENCE (2022)

Article Endocrinology & Metabolism

Kinetics and 28-day test-retest repeatability and reproducibility of [11C]UCB-J PET brain imaging

Hayel Tuncel et al.

Summary: The study aimed to evaluate the 28-day test-retest repeatability of [C-11]UCB-J brain PET imaging in Alzheimer's disease patients and healthy controls, showing that the 1T2k_V-B model can well describe the kinetics of [C-11]UCB-J.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2021)

Article Clinical Neurology

Association of Aβ deposition and regional synaptic density in early Alzheimer's disease: a PET imaging study with [11C]UCB-J

Ryan S. O'Dell et al.

Summary: This study found a significant inverse association between global Aβ deposition and synaptic binding in early AD patients with aMCI, but not in those with mild dementia. Exploratory analyses did not reveal broad or consistent associations between global Aβ deposition and regional synaptic binding across various brain regions.

ALZHEIMERS RESEARCH & THERAPY (2021)

Article Clinical Neurology

In vivo tau pathology is associated with synaptic loss and altered synaptic function

Emma M. Coomans et al.

Summary: The study found that in Alzheimer's disease, tau pathology is closely associated with reduced synaptic density and synaptic dysfunction, which may lead to slowing of neuronal activity. These results are related to the within-subject neocortical tau load and indicate a complex interaction between tau pathology, synaptic density, and synaptic function in Alzheimer's disease.

ALZHEIMERS RESEARCH & THERAPY (2021)

Article Endocrinology & Metabolism

Comparison of [11C]UCB-J and [18F]FDG PET in Alzheimer's disease: A tracer kinetic modeling study

Ming-Kai Chen et al.

Summary: We conducted a comparison study on the synaptic density and metabolism in AD and CN participants using [C-11]UCB-J PET and [F-18]FDG PET, finding a similar reduction in the medial temporal lobe but a discordant reduction in neocortical regions, with higher correlations between synaptic density and metabolism in the former.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2021)

Article Neurosciences

Effect of age on brain metabotropic glutamate receptor subtype 5 measured with [18F]FPEB PET

Adam P. Mecca et al.

Summary: Aging is associated with decreased availability of mGluR5 in the brain, primarily due to tissue loss. This reduction in mGluR5 binding may provide insight into age-related molecular changes and their relationship with brain tissue loss.

NEUROIMAGE (2021)

Article Neurosciences

Partial volume correction analysis for 11C-UCB-J PET studies of Alzheimer's disease

Yihuan Lu et al.

Summary: The purpose of the study is to reveal SV2A changes between Alzheimer's disease patients and cognitive normal participants using partial volume correction algorithms. In the hippocampus region, the IY algorithm increased the significance of group differences. MG algorithm may increase GM binding values to a greater extent. The results suggest that PVC is important for adjusting significant volume reduction.

NEUROIMAGE (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

In vivo imaging of synaptic loss in Alzheimer's disease with [18F]UCB-H positron emission tomography

Christine Bastin et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)

Review Neurosciences

Amyloid-beta-independent regulators of tau pathology in Alzheimer disease

Rik van der Kant et al.

NATURE REVIEWS NEUROSCIENCE (2020)

Article Clinical Neurology

In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET

Adam P. Mecca et al.

ALZHEIMERS & DEMENTIA (2020)

Review Biochemistry & Molecular Biology

The Rise of Synaptic Density PET Imaging

Guillaume Becker et al.

MOLECULES (2020)

Article Neurosciences

Synaptic vesicle protein 2A as a potential biomarker in synaptopathies

Kerstin Heurling et al.

MOLECULAR AND CELLULAR NEUROSCIENCE (2019)

Article Cell Biology

Imaging synaptic density in the living human brain

Sjoerd J. Finnema et al.

SCIENCE TRANSLATIONAL MEDICINE (2016)

Article Multidisciplinary Sciences

Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer's pathology

Taylor W. Schmitz et al.

NATURE COMMUNICATIONS (2016)

Review Pharmacology & Pharmacy

Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease

Cassia R. Overk et al.

BIOCHEMICAL PHARMACOLOGY (2014)

Review Neurosciences

The ageing cortical synapse: hallmarks and implications for cognitive decline

John H. Morrison et al.

NATURE REVIEWS NEUROSCIENCE (2012)

Article Multidisciplinary Sciences

MicroRNA regulation of homeostatic synaptic plasticity

Jonathan E. Cohen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Geriatrics & Gerontology

Synaptic proteins, neuropathology and cognitive status in the oldest-old

Elizabeth Head et al.

NEUROBIOLOGY OF AGING (2009)

Article Clinical Neurology

Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment

Scott E. Counts et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)

Article Geriatrics & Gerontology

Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies

SW Scheff et al.

NEUROBIOLOGY OF AGING (2003)

Review Neurosciences

The prefrontal cortex and cognitive control

EK Miller

NATURE REVIEWS NEUROSCIENCE (2000)